(Q44596370)

English

Comorbid Major Depressive Disorder as a Prognostic Factor in Cocaine‐Abusing Buprenorphine‐Maintained Patients Treated with Desipramine and Contingency Management

scientific article published on August 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management (English)

1 reference

Europe PubMed Central

4 December 2017

Comorbid Major Depressive Disorder as a Prognostic Factor in Cocaine‐Abusing Buprenorphine‐Maintained Patients Treated with Desipramine and Contingency Management (English)

1 reference

10.1081/ADA-120023455

https://api.crossref.org/works/10.1081/ADA-120023455

14 March 2024

major depressive disorder

1 reference

based on heuristic

inferred from title

author name string

Gerardo Gonzalez

1

1 reference

Europe PubMed Central

4 December 2017

Alan Feingold

2

1 reference

Europe PubMed Central

4 December 2017

Alison Oliveto

3

1 reference

Europe PubMed Central

4 December 2017

Kishor Gonsai

4

1 reference

Europe PubMed Central

4 December 2017

Thomas R. Kosten

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510037

14 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14510037

14 March 2024

publication date

1 August 2003

1 reference

Europe PubMed Central

4 December 2017

full work available at URL

http://www.tandfonline.com/doi/pdf/10.1081/ADA-120023455

1 reference

10.1081/ADA-120023455

https://api.crossref.org/works/10.1081/ADA-120023455

14 March 2024

American Journal of Drug and Alcohol Abuse

1 reference

Europe PubMed Central

4 December 2017

29

1 reference

Europe PubMed Central

4 December 2017

3

1 reference

Europe PubMed Central

4 December 2017

497-514

1 reference

Europe PubMed Central

4 December 2017

Enhanced treatment outcomes for cocaine-using methadone patients

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Six-month prevalence of psychiatric disorders in three communities 1980 to 1982.

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Psychiatric diagnoses of treatment-seeking cocaine abusers.

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Depressive symptoms modulate the subjective and physiological response to cocaine in humans

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Desipramine facilitation of initial cocaine abstinence.

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Pharmacotherapy improves treatment outcome in depressed cocaine addicts.

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine.

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude.

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Contingency management in outpatient methadone treatment: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

The Fifth Edition of the Addiction Severity Index

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

Predictors of outcome in treatment of opiate addicts: Evidence for the multidimensional nature of addicts' problems

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023455

21 January 2018

NIDA research monograph

10

95

322

author name string

Arndt I

publication date

1989

1 reference

10.1081/ADA-120023455

https://api.crossref.org/works/10.1081/ADA-120023455

14 March 2024

Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude

19

1 reference

10.1081/ADA-120023455

https://api.crossref.org/works/10.1081/ADA-120023455

14 March 2024

Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance

20

1 reference

10.1081/ADA-120023455

https://api.crossref.org/works/10.1081/ADA-120023455

14 March 2024

Contingency management treatment of outpatient unipolar depression: a comparison of reinforcement and extinction.

22

1 reference

10.1081/ADA-120023455

https://api.crossref.org/works/10.1081/ADA-120023455

14 March 2024

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

28

1 reference

10.1081/ADA-120023455

https://api.crossref.org/works/10.1081/ADA-120023455

14 March 2024

Asymptotically Efficient Rank Invariant Test Procedures

33

1 reference

10.1081/ADA-120023455

https://api.crossref.org/works/10.1081/ADA-120023455

14 March 2024

Identifiers

10.1081/ADA-120023455

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44596370&oldid=2101869710"